Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596657 · ClinicalTrials.gov registry record · NA
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
A NA study of Covid19 and Respiratory Tract Infections, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 877
- Enrollment target
- 1
- Study location
NCT04596657 is a NA study of Covid19 and Respiratory Tract Infections that has completed, run by The Cooper Health System. The registered enrollment target is 877 participants, below the 2,693-participant average among 94 other Covid19 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04596657, a NA study of Covid19 and Respiratory Tract Infections, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 877 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3 supplementation can prevent respiratory tract infections, influenza-like illness and covid-19 in hospital workers.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D supplementation
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 877 participants |
| Start Date | 2020-10-27 |
| Est. Completion | 2023-10-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04596657
The ClinicalTrials.gov registry entry for NCT04596657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 877 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,693-participant average among 94 other Covid19 trials with a reported enrollment target (67% lower). The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D supplementation is the first listed.
NCT04596657 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT04596657 about?
NCT04596657 is a clinical study titled "Vitamin D3 Supplementation to Prevent Respiratory Tract Infections". The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3 supplementation can prevent respiratory tract infections, influenza-like illness and covid-19 in hospital workers.
What is the current status of trial NCT04596657?
This trial is currently completed. It is a NA study. The enrollment target is 877 participants. The study started on 2020-10-27. Estimated completion is 2023-10-19.
What conditions does trial NCT04596657 study?
This clinical trial studies the following conditions: Covid19, Respiratory Tract Infections, Flu Like Illness.
What interventions are being tested in trial NCT04596657?
The interventions under investigation include: Vitamin D supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04596657?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04596657 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
RECRUITING · NA
-
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
ACTIVE NOT RECRUITING · NA
-
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
ACTIVE NOT RECRUITING · NA
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Implementation of COVID-19 Testing Strategies in Community Health Centers
COMPLETED · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.